Journal of Neurology

, 254:789 | Cite as

Increased serotonin transporter availability in the brainstem of migraineurs

  • Sigrid Schuh-Hofer
  • Matthias Richter
  • Lilli Geworski
  • Arno Villringer
  • Heike Israel
  • Rüdiger Wenzel
  • Dieter Ludwig Munz
  • Guy Arnold
ORIGINAL COMMUNICATION

Abstract

For decades, serotonin has been speculated to play a major role in migraine pathophysiology. The central serotonergic system is located in the raphe nuclei and the adjacent reticular formation in the brainstem. Recently, radioligands targeting the brain serotonin transport protein (SERT) have been developed. We used the highly specific SERT-radioligand 123I-ADAM [2-((2-((dimethylamino) methyl)phenyl)thio)-5-iodophenylamine] to test the hypothesis of the mesopontine serotonergic system being involved in the pathophysiology of migraine. Nineteen migraine patients and 10 healthy, age- and sex-matched controls were enrolled. The neuroimaging study was performed interictally during the pain-free interval. Single Photon Emission Computed Tomography (SPECT)-images were coregistered with MRI-scans. Region of interest (ROI)-analysis revealed a highly significant increase of 123I-ADAM uptake in the mesopontine brainstem of migraineurs (p < 0.001). In contrast, 123IADAM uptake in the thalamus did not differ significantly between migraineurs and controls. Our study demonstrates for the first time a significant increase of brainstem SERT-availability in migraineurs, suggesting a dysregulation of the brainstem serotonergic system. It remains to be elucidated whether the altered SERT-availability is causally related to migraine pathophysiology or whether it reflects secondary pathophysiological mechanisms.

References

  1. 1.
    Afridi SK, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ (2005) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128:932–939CrossRefPubMedGoogle Scholar
  2. 2.
    Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RS, Goadsby PJ (2005) A positron emission tomographic study in spontaneous migraine. Arch Neurol 62:1270–1275CrossRefPubMedGoogle Scholar
  3. 3.
    Anthony M, Hinterberger H, Lance JW (1967) Plasma serotonin in migraine and stress. Arch Neurol 16:544–552PubMedGoogle Scholar
  4. 4.
    Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ (2001) Brainstem activation specific to migraine headache. Lancet 357:1016–1017CrossRefPubMedGoogle Scholar
  5. 5.
    Baumgarten HG, Grodzdanovic Z (2000) Anatomy of central serotoninergic projection systems. In: Baumgarten HG, Go¨thert M (eds) Serotoninergic neurons and 5-HT receptors in the CNS. Springer Berlin, Heidelberg New York, pp 41–89Google Scholar
  6. 6.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedGoogle Scholar
  7. 7.
    Borroni B, Brambilla C, Liberini P, Rao R, Archetti S, Gipponi S, Volta GD, Padovani A (2005) Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J Headache Pain 6:182–184CrossRefPubMedGoogle Scholar
  8. 8.
    Chugani DC, Niimura K, Chaturvedi S, Muzik O, Fakhouri M, Lee ML, Chugani HT (1999) Increased brain serotonin synthesis in migraine. Neurology 53:1473–1479PubMedGoogle Scholar
  9. 9.
    Curran DA, Hinterberger H, Lance JW (1965) Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxym-methoxymandelic acid excretion in normal and migrainous subjects. Brain 88:997–1010CrossRefPubMedGoogle Scholar
  10. 10.
    D’Andrea G, Cananzi AR, Perini F, Hasselmark L (1995) Platelet models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia 15:265–271CrossRefPubMedGoogle Scholar
  11. 11.
    Ferrari MD, Saxena PR (1993) On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13:151–165CrossRefPubMedGoogle Scholar
  12. 12.
    Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):9–160CrossRefGoogle Scholar
  13. 13.
    Hesse S, Barthel H, Schwarz J, Sabri O, Muller U (2004) Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev 28:547–563CrossRefPubMedGoogle Scholar
  14. 14.
    Huang WS, Ma KH, Cheng CY, Chen CY, Fu YK, Chou YH, Wey SP, Liu JC (2004) Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non–human primates. Nucl Med Commun 25:515–519CrossRefPubMedGoogle Scholar
  15. 15.
    Hudson HM, Larkin RS (1994) Accelerated image reconstruction using ordered subsets of projection data. Trans Med Imaging 13:601–609CrossRefGoogle Scholar
  16. 16.
    Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M, Inoue M, Yasuno F, Takano A, Maeda J, Shibuya H (2002) Serotonin transporter binding in patients with mood disorders; a PET study with [11C] (+)McN5652. Biol Psychiatry 51:715–722CrossRefPubMedGoogle Scholar
  17. 17.
    Juhasz G, Zsombok T, Laszik A, Gonda X, Sotonyi P, Faludi G, Bagdy G (2003) Association analysis of 5-HTTLPR variants, 5-HT (2A) receptor gene 102T/C polymorphism and migraine. J Neurogenet 17:231–240PubMedGoogle Scholar
  18. 18.
    Katsarava Z, Egelhof T, Kaube H, Diener HC, Limmroth V (2003) Symptomatic migraine and sensitization of trigeminal nociception associated with contralateral pontine cavernoma. Pain 105:381–384CrossRefPubMedGoogle Scholar
  19. 19.
    Kauppinen TA, Bergström KA, Heikman P, Hiltunen J, Ahonen AK (2003) Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results. Eur J Nucl Med Mol Imaging 30:132–136CrossRefPubMedGoogle Scholar
  20. 20.
    Kimball RW, Friedmann AP, Vallejo E (1960) Effect of serotonin in migraine patients. Neurology 10:10–111Google Scholar
  21. 21.
    Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E (2002) A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 42:893–895CrossRefPubMedGoogle Scholar
  22. 22.
    Kuikka JT (2004) Quantitative accuracy of serotonergic neurotransmission imaging with high-resolution 123I SPECT. Nuklearmedizin 43:185–189PubMedGoogle Scholar
  23. 23.
    Lesch KP (2000) Molecular biology, pharmacology, and genetics of the serotonin transporter: psychobiological and clinical implications. In: Baumgarten HG, Go¨thert M (eds) Serotoninergic neurons and 5-HT receptors in the CNS. Springer Berlin, Heidelberg New York, pp 671–705Google Scholar
  24. 24.
    Malison RT, Price LH, Berman R, vanDyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2ß-carbomethoxy-3ß-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44:1090–1098CrossRefPubMedGoogle Scholar
  25. 25.
    Marziniak M, Mossner R, Schmitt A, Lesch KP, Sommer C (2005) A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 64:157–159PubMedGoogle Scholar
  26. 26.
    May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ (1998) Hypothalamic activation in cluster headache. Lancet 352:275–278CrossRefPubMedGoogle Scholar
  27. 27.
    May A, Bahra A, Buchel C, Turner R, Goadsby PJ (1999) Functional magnetic resoncance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 46:791–794CrossRefPubMedGoogle Scholar
  28. 28.
    Ogilvie AD, Russell MB, Dhall P, Battersby S, Ulrich V, Smith CA, Goodwin GM, Harmar AJ, Olesen J (1998) Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 18:23–26CrossRefPubMedGoogle Scholar
  29. 29.
    Oya S, Choi SR, Hou C, Mu M, Kung MP, Acton PD, Siciliano M, Kung HF (2000) 2-((2-((dimethylamino) methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. Nucl Med Biol 27:249–254CrossRefPubMedGoogle Scholar
  30. 30.
    Panconesi A (1995) 5-Hydroxytryptamine parameters in the periphery: how useful are they in the study of headaches? J Serotonin Res 2:117–137Google Scholar
  31. 31.
    Radat F, Swendsen J (2005) Psychiatric comorbidity in migraine: a review. Cephalalgia 25:165–178CrossRefPubMedGoogle Scholar
  32. 32.
    Schuster A, Vollmar S, Lucht H (2004) MPI-tool, multi purpose imaging tool, Version 4. Advanced Tomo Vision (http://www.atv-gmbh.de). pp 46–49Google Scholar
  33. 33.
    Sicuteri F, Testi A, Anselmi B (1961) Biochemical investigations in headache: increase in hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy 19:55–58CrossRefGoogle Scholar
  34. 34.
    Sicuteri F (1972) Headache as possible expression of deficiency of brain 5- hydroxytryptamine (central denervation supersensitivity). Headache 12:69–72CrossRefPubMedGoogle Scholar
  35. 35.
    Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle TR (2005) SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 113:422–426CrossRefPubMedGoogle Scholar
  36. 36.
    Van Dyck CH, Malison RT, Staley JK, Jacobsen LK, Seibyl JP, Laruelle M, Baldwin RM, Innis RB, Gelernter J (2004) Central serotonin transporter availability measured with [123]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 161:525–531CrossRefPubMedGoogle Scholar
  37. 37.
    Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658–660CrossRefPubMedGoogle Scholar
  38. 38.
    Welch KM, Cao Y, Aurora S, Wiggins G, Vikingstad EM (1998) MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 51:1465–1469PubMedGoogle Scholar
  39. 39.
    Welch KM, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal grey matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637CrossRefPubMedGoogle Scholar
  40. 40.
    Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA (2001) Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci 186:27–30CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • Sigrid Schuh-Hofer
    • 1
    • 2
  • Matthias Richter
    • 3
  • Lilli Geworski
    • 3
  • Arno Villringer
    • 1
  • Heike Israel
    • 1
  • Rüdiger Wenzel
    • 1
  • Dieter Ludwig Munz
    • 3
  • Guy Arnold
    • 1
    • 4
  1. 1.Dept. of NeurologyCharité-Universitätsmedizin BerlinBerlinGermany
  2. 2.Dept. of NeurologyUniversitätsklinikum TübingenTübingenGermany
  3. 3.Clinic for Nuclear MedicineCharité-Universitätsmedizin BerlinBerlinGermany
  4. 4.Dept. of NeurologyKrankenhaus SindelfingenSindelfingenGermany

Personalised recommendations